Observational studyFrontiers in public health2025
Factors associated with viral load suppression in pregnant and postpartum women living with HIV in Rwanda: an open-observational cohort study.
Observational study in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Pooled it
- Novel application of dried blood spot tenofovir diphosphate to predict viral suppression in postpartum women with HIV in Malawi.AIDS (London, England) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Achieving and maintaining HIV viral load suppression (VLS) in pregnant and postpartum women living with HIV (WLWH) is critical for their health and to prevent mother-to-child transmission. However, data on VLS in this population are limited. This study aimed to evaluate the prevalence and factors associated with VLS among pregnant and postpartum WLWH in Rwanda within 12 months of enrolling in antenatal care. Methods: An open observational cohort study was conducted using routine clinical data from 10 Rwandan HIV clinics in Kigali City. Data from WLWH on ART who became pregnant and were referred to PMTCT services between 2012 and 2020 were analyzed. The primary outcomes were the proportion of WLWH achieving VLS (viral load (VL) <1,000 or <200 copies/mL) within 12 months of antenatal registration. Logistic regression models assessed associations of VLS with socio-demographic and clinical characteristics. Results: Among 1,002 WLWH, 532 (53%) had documented VL results. The mean age was 30.4 years, with 60% aged 25-34 years. Most (83.7%) were primigravida, and 67% initiated ART before pregnancy. At antenatal care enrollment, 58% had a CD4 count ≥500 cells/uL. Within 12 months, 92% had VL <1,000 copies/mL and 87% had a VL <200 copies/mL. Advanced HIV disease (WHO stage 3 and 4) and lower CD4 counts were associated with lower odds of VLS. Conclusion: Among those with a recorded VL results, nine out of 10 had a VLS, particularly those without advanced HIV disease. The findings underscore the need for targeted interventions for WLWH with advanced HIV entering antenatal care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.